Develops diagnostic healthcare products, including rapid diagnostic tests and immunoassays.
QuidelOrtho Corporation specializes in advancing diagnostic testing technologies across various healthcare needs. The company operates through multiple business units: Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics. Within the Labs unit, QuidelOrtho provides clinical chemistry and immunoassay instruments and tests that measure key chemicals and proteins in bodily fluids to assess health status and manage patient care. These solutions encompass a wide range of diagnostic tools tailored for monitoring disease progression and supporting therapeutic decisions across different medical fields.
In the Transfusion Medicine segment, QuidelOrtho offers immunohematology instruments and tests crucial for blood typing and ensuring compatibility between donors and recipients during transfusions. Additionally, the company provides donor screening instruments to screen blood and plasma for infectious diseases, safeguarding the safety of blood products used in medical treatments.
The Point-of-Care business unit specializes in rapid diagnostic tests designed to deliver quick results in various clinical settings outside traditional laboratories. These tests cater to the urgent and immediate needs of healthcare professionals in diverse healthcare settings.
QuidelOrtho's Molecular Diagnostics unit focuses on polymerase chain reaction (PCR) thermocyclers, analyzers, and amplification systems, empowering precise and efficient detection of genetic material for diagnostic purposes. The company markets its comprehensive range of products directly to end-users through its dedicated sales force and via a network of distributors. These products are utilized in physician offices, hospitals, clinical and reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness centers, blood banks, and donor centers worldwide. Established in 1979 and headquartered in San Diego, California, QuidelOrtho Corporation continues to innovate and expand its footprint across North America, Europe, the Middle East, Africa, China, and other international markets.